Contraceptive and therapeutic effects of drospirenone-containing hormonal antifertility agent with 24/4 dosage regimen

Abstract

This paper focuses on the use of combine hormonic contraceptive Dimia in young patients' acne treatment. It owes its effecteveness to progestin drospirenone which has high anti-androgenic activity. Prolonged treatment – by 24/4 regimen stabilizes the hormone concentration in blood due to the pituitary gonadotrophic function suppression. This dosage scheme also heightens the premenstrual syndrome and androgen dependent dermatotoses treatment efficiency.

Keywords

• drospirenone-containing oral contraceptive
• acne treatment
• premenstrual syndrome